Peptides have moved into the center of the conversation across health, aesthetics, and longevity.

This Special Report takes a closer look at what is driving that shift and what happens next.

Dr. Randi is joined by Sarah Morgan, MS, Clinical Nutritionist, who brings over 20 years of experience working across peptides, hormones, and advanced nutrient therapies, including training practitioners and supporting clinical use at scale.

Together, they break down what is happening in real time. From the surge fueled by GLP-1 medications to the policy changes already underway, this conversation examines why peptides are rapidly becoming one of the most important and complex categories in modern medicine.

Inside the episode:

• What is driving demand across clinics and patients

• The latest FDA movement and what it signals going forward

• The peptides gaining traction right now including BPC-157, GHK-Cu, and MOTS-c and more…

• Where peptides fit across skin, hair, recovery, and metabolic health

• The reality behind microdosing GLP-1s

• The growing concerns around sourcing, quality, and safety

• What happens next as access expands and innovation accelerates

This episode does not just highlight the opportunity. It addresses the responsibility that comes with a category moving this quickly and why education will define who gets it right. With major regulatory decisions approaching and new delivery formats on the horizon, peptides are entering a new phase.

If you want a clear, informed view of where this is heading, this is the episode to watch.

---

Listeners should not rely on any content from this podcast as a substitute for professional medical advice. Always consult a licensed physician or qualified healthcare provider regarding any medical concerns, treatments, or decisions. This podcast does not endorse or guarantee the safety or efficacy of any products, procedures, or services discussed.

This podcast is not intended for individuals under the age of 18.

Neither the host nor any guests assume liability for any loss, injury, or damage resulting from the use or application of the information discussed on this show.

Peptides Under the Microscope | Special Report — Sarah Morgan